Anticoagulant therapy innovations in ensuring for effectiveness and safety
Abstract
The Russian National Congress of Cardiology 2020 was held from September 29 to October 1. Due to the unfavorable epidemiological issues congress switched into online – 149 meetings in 15 virtual rooms. All the meetings were recorded and uploaded to the YouTube channel of the Russian Cardiological Society. There was a decent discussion about cardiology and multidisciplinary interaction. Special attention was payed to recently updated ESC Guidelines on Atrial Fibrillation 2020. Over the past 10 years, anticoagulant therapy has gone through a series of major events. The new guidelines have been generally well approved by both medical community and patients. Comprehensive assessment of risk factors in patients with atrial fibrillation is a key for the prescription of adequate treatment considering effectiveness and safety. The new era of direct oral anticoagulants was represented at satellite symposia by opinion leaders in cardiology.
Review
For citations:
Tindalsky V. Anticoagulant therapy innovations in ensuring for effectiveness and safety. Lechaschi Vrach. 2020;(11):60-63. (In Russ.)
JATS XML


















